Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

PAPST2 Inhibitors

PAPST2, formally known as 3'-phosphoadenosine 5'-phosphosulfate transporter 2, is integral to the cellular sulfation pathway, a critical biochemical process that facilitates the transfer of sulfate groups to various biomolecules, including proteins, peptides, and lipids. This protein is responsible for the transport of 3'-phosphoadenosine 5'-phosphosulfate (PAPS)-the universal sulfate donor-from the cytosol, where it is synthesized, to the Golgi apparatus, where the sulfation reactions predominantly occur. By mediating the availability of PAPS in the Golgi, PAPST2 directly influences the sulfation efficiency of a myriad of molecules, which is essential for their activity, metabolism, and clearance. The sulfation process governed by PAPST2 is pivotal for numerous biological functions such as cell signaling, molecular recognition, and the modulation of enzymatic activities. Thus, the inhibition of PAPST2 could lead to a decrease in the cellular capacity to sulfate biomolecules, potentially affecting a wide range of physiological processes and leading to various pathological conditions.

The inhibition of PAPST2 can occur through several mechanisms, including the downregulation of its expression, interference with its ability to transport PAPS, or the destabilization of the protein itself. Such inhibition can lead to a reduced sulfation of target molecules, which may have significant biological consequences given the importance of sulfation in enhancing the molecular function, solubility, and clearance of substrates. For instance, the decreased sulfation of glycosaminoglycans, which are critical components of the extracellular matrix, could affect tissue structure and function. Similarly, the reduced sulfation of hormones and neurotransmitters could impair signal transduction pathways, leading to dysregulation of physiological responses. The mechanisms behind the inhibition of PAPST2 are complex and involve various regulatory pathways that can affect the protein's transcription, translation, post-translational modifications, and intracellular trafficking. Understanding these inhibitory mechanisms is crucial for elucidating the role of sulfation in health and disease and could provide insights into potential targets for intervention in conditions where aberrant sulfation is implicated.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

Interferes with nucleotide binding sites, potentially altering PAPST2 activity by competitive inhibition.

Probenecid

57-66-9sc-202773
sc-202773A
sc-202773B
sc-202773C
1 g
5 g
25 g
100 g
$28.00
$39.00
$100.00
$277.00
28
(2)

May block nucleotide transporters, indirectly reducing substrate availability for PAPST2.

Sodium Salicylate

54-21-7sc-3520
sc-3520A
sc-3520B
sc-3520C
1 g
25 g
500 g
1 kg
$10.00
$26.00
$82.00
$139.00
8
(1)

Could modulate nucleotide metabolism, affecting PAPST2 activity by altering its substrate pool.

Ellagic Acid, Dihydrate

476-66-4sc-202598
sc-202598A
sc-202598B
sc-202598C
500 mg
5 g
25 g
100 g
$58.00
$95.00
$245.00
$727.00
8
(1)

Antioxidant that can bind to nucleotide-binding proteins, potentially inhibiting PAPST2 by this interaction.

Pyridoxal-5-phosphate

54-47-7sc-205825
5 g
$104.00
(1)

Coenzyme that can bind to active sites of enzymes, possibly altering the activity of PAPST2.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$63.00
$110.00
$214.00
1
(1)

Nucleoside analogue that may compete with natural substrates of PAPST2, leading to inhibition.

Tiazofurin

60084-10-8sc-475805
5 mg
$449.00
(0)

Inhibits nucleotide synthesis, possibly reducing PAPST2 activity by limiting substrate availability.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

Inhibits de novo guanine synthesis, potentially decreasing the substrate for PAPST2.

2-Chloro-2′-deoxyadenosine

4291-63-8sc-202399
10 mg
$144.00
1
(0)

Nucleoside analogue that can be incorporated into DNA, potentially disrupting PAPST2-related pathways.

Allopurinol

315-30-0sc-207272
25 g
$131.00
(0)

Xanthine oxidase inhibitor that may indirectly affect nucleotide levels and thereby PAPST2 activity.